COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,580 Articles (22,415 medRxiv, 8,165 bioRxiv)

Most recent first Previous |  Page 2244: Articles 22431-22440  | Next

SARS-CoV-2 infects human pluripotent stem cell-derived cardiomyocytes, impairing electrical and mechanical function
Marchiano, S., Hsiang, T.-Y., Higashi, T., Kanna, A., Reinecke, H., Yang, X., Pabon, L., Sniadecki, N. J., Bertero, A., Gale, M., Murry, C. E.
10.1101/2020.08.30.274464 — Posted: 2020-08-30 Discussion: Onsite
Structural classification of neutralizing antibodies against the SARS-CoV-2 spike receptor-binding domain suggests vaccine and therapeutic strategies
Barnes, C. O., Jette, C. A., Abernathy, M. E., Dam, K.-M. A., Esswein, S. R., Gristick, H. B., Malyutin, A. G., Sharaf, N. G., Huey-Tubman, K. E., Lee, Y. E., Robbiani, D. F., Nussenzweig, M. C., West, A. P., Bjorkman, P. J.
10.1101/2020.08.30.273920 — Posted: 2020-08-30
The global landscape of SARS-CoV-2 genomes, variants, and haplotypes in 2019nCoVR
Song, S., Ma, L., Zou, D., Tian, D., Li, C., Zhu, J., Chen, M., Wang, A., Ma, Y., Li, M., Teng, X., Cui, Y., Duan, G., Zhang, M., Jin, T., Shi, C., Du, Z., Zhang, Y., Liu, C., Li, R., Zeng, J., Hao, L., Jiang, S., Chen, H., Han, D., Xiao, J., Zhang, Z., Zhao, W., Xue, Y., Bao, Y.
10.1101/2020.08.30.273235 — Posted: 2020-08-30
Structure-Altering Mutations of the SARS-CoV-2 Frame Shifting RNA Element
Schlick, T., Zhu, Q., Jain, S., Yan, S.
10.1101/2020.08.28.271965 — Posted: 2020-08-30
Antibody response to SARS-CoV-2 infection in humans: a systematic review
Post, N., Eddy, D., Huntley, C., van Schalkwyk, M. C. I., Shrotri, M., Leeman, D., Rigby, S., Williams, S. V., Bermingham, W. H., Kellam, P., Maher, J., Shields, A. M., Amirthalingam, G., Peacock, S. J., Ismail, S. A.
10.1101/2020.08.25.20178806 — Posted: 2020-08-30
Real-time Nowcasting and Forecasting of COVID-19 Dynamics in England: the first wave?
Birrell, P. J., Blake, J., van Leeuwen, E., PHE Joint Modelling Cell, , Gent, N., De Angelis, D.
10.1101/2020.08.24.20180737 — Posted: 2020-08-30
Silicon Nitride Inactivates SARS-CoV-2 in vitro
Lehman, C. W., Flur, R., Kehn-Hall, K., McEntire, B. J., Bal, B. S., Bock, R. M.
10.1101/2020.08.29.271015 — Posted: 2020-08-29
Global BioID-based SARS-CoV-2 proteins proximal interactome unveils novel ties between viral polypeptides and host factors involved in multiple COVID19-associated mechanisms
Laurent, E. M., Sofianatos, Y., Komarova, A., Gimeno, J.-P., Samavarchi Tehrani, P., Kim, D.-K., Abdouni, H., Duhamel, M., Cassonnet, P., Knapp, J. J., Kuang, D., Chawla, A., Sheykhkarimli, D., Rayhan, A., Li, R., Pogoutse, O., Hill, D. E., Calderwood, M. E., Falter-Braun, P., Aloy, P., Stelzl, U., Vidal, M., Gingras, A.-C., Pavlopoulos, G. A., Van Der Werf, S., Fournier, I., Roth, F. P., Salzet, M., Demeret, C., Jacob, Y., Coyaud, E.
10.1101/2020.08.28.272955 — Posted: 2020-08-29 Discussion: Onsite
Establishment of murine hybridoma cells producing antibodies against spike protein of SARS-CoV-2
Antipova, N. V., Larionova, T. D., Shakhparonov, M. I., Pavlyukov, M. S.
10.1101/2020.08.29.272963 — Posted: 2020-08-29
Single-cell analysis of human trophoblast stem cell specification reveals activation of fetal cytotrophoblast expression programs including coronavirus associated host factors and human endogenous retroviruses
Tietze, E., Barbosa, A. R., Euclydes, V., Cho, H. J., Lee, Y. K., Feltrin, A., Leemput, J. v. d., Carlo, P. D., Sawada, T., Benjamin, K. J., Brentani, H., Kleinman, J. E., Hyde, T. M., Weinberger, D. A., Ursini, G., McKay, R., Paquola, A. C. M., Shin, J. H., Erwin, J. A.
10.1101/2020.08.29.273425 — Posted: 2020-08-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).